Document is current
Any future updates will be listed below
-
Authors
Nie, Yusuke
Fujiyama, Yoshiki
Shibaki, Shumpei
Okamoto, Riku
Okuno, Kota
Oki, Keiko
Watanabe, Akiko
Kuroda, Yu
Goto, Takuya
Yokota, Kazuko
Kojima, Keita
Harada, Hiroki
Kidachi, Mikiko
Soeno, Takafumi
Yokota, Mitsuo
Kaida, Takeshi
Nakamoto, Shuji
Nishizawa, Nobuyuki
Kubo, Hidefumi
Tajima, Hiroshi
Kaizu, Takashi
Yamanashi, Takahiro
Nakamura, Masaki
Kitasato, Hidero
Yoshida, Tsutomu
Murakumo, Yoshiki
Saegusa, Makoto
Sangai, Takafumi
Hiki, Naoki
Naitoh, Takeshi
Kumamoto, Yusuke
Yamashita, Keishi https://orcid.org/0000-0002-8492-0300
-
Funding
Funding for this research was provided by:
Grants-in-Aid for Scientific Research from Princess Takamatsu Cancer Research Fund
Uehara Memorial Foundation
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 23 July 2025
First Online: 20 August 2025
Disclosure
: Takeshi Naitoh has received honoraria from Chugai Pharmaceutical, Taiho Pharmaceutical, Takeda Pharmaceutical, Eli Lilly Japan, and Daiichi Sankyo. Yusuke Nie, Yoshiki Fujiyama, Shumpei Shibaki, Riku Okamoto, Kota Okuno, Keiko Oki, Akiko Watanabe, Yu Kuroda, Takuya Goto, Kazuko Yokota, Keita Kojima, Hiroki Harada, Mikiko Kidachi, Takafumi Soeno, Mitsuo Yokota, Takeshi Kaida, Shuji Nakamoto, Nobuyuki Nishizawa, Hidefumi Kubo, Hiroshi Tajima, Takashi Kaizu, Takahiro Yamanashi, Masaki Nakamura, Hidero Kitasato, Tsutomu Yoshida, Yoshiki Murakumo, Makoto Saegusa, Takafumi Sangai, Naoki Hiki, Yusuke Kumamoto, and Keishi Yamashita have no disclosures to declare that may be relevant to the contents of this study.
